載入...
The world of targeted therapies in kidney cancers: pitfalls, tips and tricks
In the past few years, metastatic renal cell carcinoma prognosis was improved by the development of molecular targeted therapies (TTs). At the metastatic stage, the tolerance to treatment is a major concern, not only because of the challenge of the efficacy/toxicity ratio improvement but also becaus...
Na minha lista:
| 發表在: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344426/ https://ncbi.nlm.nih.gov/pubmed/28424553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S127919 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|